These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35022247)

  • 1. Testing of the therapeutic efficacy and safety of AMPA receptor RNA aptamers in an ALS mouse model.
    Akamatsu M; Yamashita T; Teramoto S; Huang Z; Lynch J; Toda T; Niu L; Kwak S
    Life Sci Alliance; 2022 Apr; 5(4):. PubMed ID: 35022247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice.
    Akamatsu M; Yamashita T; Hirose N; Teramoto S; Kwak S
    Sci Rep; 2016 Jun; 6():28649. PubMed ID: 27350567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
    Kwak S; Kawahara Y
    J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.
    Yamashita T; Kwak S
    Neurosci Res; 2019 Jul; 144():4-13. PubMed ID: 29944911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.
    Hosaka T; Tsuji H; Kwak S
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
    Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
    Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPA receptor-mediated neuronal death in sporadic ALS.
    Kwak S; Hideyama T; Yamashita T; Aizawa H
    Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis.
    Yamashita T; Akamatsu M; Kwak S
    Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2.
    Hideyama T; Yamashita T; Suzuki T; Tsuji S; Higuchi M; Seeburg PH; Takahashi R; Misawa H; Kwak S
    J Neurosci; 2010 Sep; 30(36):11917-25. PubMed ID: 20826656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calpain plays a crucial role in TDP-43 pathology].
    Yamashita T; Kwak S
    Rinsho Shinkeigaku; 2014; 54(12):1151-4. PubMed ID: 25672733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?
    Kawahara Y; Kwak S
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):131-44. PubMed ID: 16183555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate receptors: RNA editing and death of motor neurons.
    Kawahara Y; Ito K; Sun H; Aizawa H; Kanazawa I; Kwak S
    Nature; 2004 Feb; 427(6977):801. PubMed ID: 14985749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
    Kwak S
    Brain Nerve; 2012 May; 64(5):549-56. PubMed ID: 22570068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perampanel for Sporadic Amyotrophic Lateral Sclerosis].
    Aizawa H; Kwak S
    Brain Nerve; 2019 Nov; 71(11):1270-1278. PubMed ID: 31722313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When Does ALS Start? ADAR2-GluA2 Hypothesis for the Etiology of Sporadic ALS.
    Hideyama T; Kwak S
    Front Mol Neurosci; 2011; 4():33. PubMed ID: 22102833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative features of sporadic amyotrophic lateral sclerosis: Motor neurons of Onuf's nucleus survive in ADAR2-conditional knockout mice.
    Hideyama T; Teramoto S; Kato H; Terashi H; Kwak S; Aizawa H
    J Neurol Sci; 2024 Aug; 463():123142. PubMed ID: 39053342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS.
    Sun H; Kawahara Y; Ito K; Kanazawa I; Kwak S
    J Neurochem; 2006 Aug; 98(3):782-91. PubMed ID: 16893420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons.
    Yamashita T; Chai HL; Teramoto S; Tsuji S; Shimazaki K; Muramatsu S; Kwak S
    EMBO Mol Med; 2013 Nov; 5(11):1710-9. PubMed ID: 24115583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
    Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
    J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.